A significant increase in Bcl-2 expression has been found in PCa tumours that progressed following radiotherapy compared to those where radical prostatectomy was used as the primary treatment, demonstrating the potential of elevated Bcl-2 to act as a marker of radioresistance [50]. This evidence concerns the gene BCL2 and neoplasm.